Transfection of si-TUBA1B into the selected breast cancer cell lines at various time points (24 h, 48 h, 72 h) resulted in a significant reduction in cell proliferation and viability (Figs. 13H–I; S7B–C). This evidence concerns the gene TUBA1B and breast carcinoma.